FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and medicine, and concerns application of sophoricoside.
EFFECT: preparing the drug applicable for preventing and/or treating articular cartilage degeneration or osteoarthritis in postmenopausal females, exhibiting side-effect-free high efficacy.
6 cl, 11 dwg, 5 tbl, 7 ex
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITION CONTAINING HYDANTOIN DERIVATIVES |
2014 |
- Noda Khirosi
- Kitamura Khidetomo
- Tamura Tatsuya
|
RU2701168C2 |
| SCHEME FOR USING FGF-18 COMPOUND |
2015 |
- Ladel, Christoph H.
- Guehring, Hans
|
RU2700582C2 |
| αvβ3 SELECTIVE POLYPEPTIDE, METHOD FOR PREPARING IT, POLYNUCLEOTIDE CODING IT, COMPOSITION CONTAINING SAID PEPTIDE, AND METHOD FOR TREATING AND PREVENTING |
2007 |
- Chuan Voehj-Tszer
- Fu Vehn'-Mehj
- Khuan Tur-Fu
- Khuan Vehn'Ja
- Tan Chikh-Khsin
- Chehn' Chiu-Juehkh
|
RU2477727C2 |
| PHARMACEUTICAL COMPOSITION AND SET FOR TREATMENT OF REDUCED OSSEOUS MASS (VERSIONS) |
1996 |
- Ke Khua Zu
- Tompson Dehvid D.
|
RU2190395C2 |
| CALCITONIN USED AT OSTEOARTHRITIS |
2004 |
- Atsria Mojze
- Kristiansen Klaus
- Bejtman Sajmon Dejvid
- Li Shoufen
|
RU2368390C2 |
| SCHEME FOR USING FGF-18 COMPOUND |
2015 |
- Ladel, Christoph H.
- Guehring, Hans
|
RU2691946C2 |
| GASTRIN ANTAGONISTS FOR TREATING AND PREVENTING OSTEOPOROSIS |
2014 |
- Kidd Mark
- Modlin Irvin Mark
|
RU2693484C1 |
| COMPOSITION FOR PREVENTION, RELIEF, OR TREATMENT OF DISEASES OR SYMPTOMS RELATED TO CARTILAGES, INCLUDING HAPLN1 |
2019 |
- Kim, Dae Kyong
- Jang, Ji Min
|
RU2788162C2 |
| METHOD FOR APPLYING ANNEALED PYRROLE COMPOUNDS WHEN TREATING ARTICULAR CARTILAGE DEGENERATION OR STRUCTURAL SUBCHONDRAL BONE TRANSFORMATIONS |
2002 |
- Pellet'E Zhan-P'Er
- Martel'-Pellet'E Zhoann
|
RU2303447C2 |
| APPLICATION OF CXCL6 CHEMOKINE DURING PREVENTION OR ELIMINATION OF CARTILAGE DEFECTS |
2004 |
- Ljuten Frank
- De Bari Kozimo
- Del'`Achcho Franchesko
|
RU2363491C2 |
